XM không cung cấp dịch vụ cho cư dân của Mỹ.
A
A

Amgen


Tin tức

Amid an uncertain landscape, high quality may offer stable ground

LIVE MARKETS-Amid an uncertain landscape, high quality may offer stable ground Dow and S&P 500 climb, Nasdaq off ~0.2% Financials lead S&P 500 sector gainers; Comm Svcs weakest group Euro STOXX 600 index up ~0.5% Dollar slips; gold, crude both off ~1%; bitcoin off >2% U.S. 10-Year Treasury yield dips to ~3.82% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
A
G
K
N
V
G
U
U
F
I
S
U
A
G
B

Amgen sues Samsung biotech unit over bone drug copies

Amgen sues Samsung biotech unit over bone drug copies By Blake Brittain Aug 13 (Reuters) - Amgen AMGN.O has sued Samsung's biologics unit 207940.KS in New Jersey federal court over its proposed biosimilar versions of Amgen's blockbuster bone drugs Prolia and Xgeva. Amgen's lawsuit against Samsung Bioepis, filed on Monday, said the biosimilars would infringe 34 patents covering Amgen drugs.
A

Amgen To Open New Site In Hyderabad, India

BRIEF-Amgen To Open New Site In Hyderabad, India Aug 9 (Reuters) - Amgen Inc AMGN.O : AMGEN TO OPEN NEW SITE IN HYDERABAD, INDIA Source text for Eikon: ID:nPreCsdBha Further company coverage: AMGN.O
A

Tech surge, BOJ's dovish comments boost Wall Street

US STOCKS-Tech surge, BOJ's dovish comments boost Wall Street For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps on FY revenue forecast raise Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.36%, Nasdaq 1.64%, Dow 0.9% Updated at 11:22 a.m.
A
A
T
U
U
U
U
D

U.S. STOCKS Abbott Laboratories, Medtronic, Axon

BUZZ-U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week which partly sparked heavy volatility in global markets.
A
A
C
F
I
T
U
U
L

Wall St charges ahead as Big Tech relief rally continues

US STOCKS-Wall St charges ahead as Big Tech relief rally continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.2%, Nasdaq 1.7%, Dow 0.7% Updated at 9:35 a.m.
A
A
N
U
U
U
U
D

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Wall St set to open higher as Big Tech buying continues

US STOCKS-Wall St set to open higher as Big Tech buying continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: S&P 500 1%, Nasdaq 1.18%, Dow 0.72% Updated at 8:25 a.m.
A
A
M
N
U
W
U
U
U
D

U.S. STOCKS Walt Disney, SpringWorks, Shopify

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
F
T
U
L
S

Futures advance as Big Tech continues to recover

US STOCKS-Futures advance as Big Tech continues to recover For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: Dow 0.8%, S&P 1.2%, Nasdaq 1.5% Updated at 7:05 a.m.
A
A
M
N
U
W
U
U
U
D

Futures rally as Big Tech extends recovery

US STOCKS-Futures rally as Big Tech extends recovery For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Futures up: S&P 500 1.05%, Nasdaq 1.21%, Dow 0.79% Aug 7 (Reuters) - U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
B
U
U
U
U
D
A

Amgen falls as Q2 profit slips

BUZZ-Amgen falls as Q2 profit slips ** Drugmaker Amgen's AMGN.O shares fall 4% to $315.51 premarket ** Co late on Tuesday reported Q2 adjusted profit of $4.97 per share, largely in-line with average analyst estimate -LSEG data ** Adj. profit slipped 1% year-over-year hurt by higher expenses, including costs related to development of its experimenta
A

U.S. Amgen, Atkore, MoneyLion

U.S. RESEARCH ROUNDUP-Amgen, Atkore, MoneyLion Aug 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Atkore and MoneyLion on Wednesday. HIGHLIGHTS * Amgen Inc AMGN.O : RBC raises target price to $362 from $332 * Atkore Inc ATKR.N : RBC cuts to sector perform from outperform * MoneyLion ML.N : Needham cuts target price to $70 from $100 * Progyny Inc PGNY.O : BTIG cuts to neutral from buy * Truecar Inc TRUE.O :
A
A
A
B
B

Amgen Inc reports results for the quarter ended in June - Earnings Summary

Amgen Inc reports results for the quarter ended in June - Earnings Summary Amgen Inc AMGN.OQ reported quarterly adjusted earnings of $4.97​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of $5.00. The mean expectation of twenty two analysts for the quarter was for earnings of $5.01 per share.
A

Amgen falls on downbeat second-quarter profit

BUZZ-Amgen falls on downbeat second-quarter profit ** Shares of drugmaker Amgen AMGN.O fall ~1.8% to $322.99 in after-market trade ** AMGN reports Q2 adj. profit of $4.97/shr vs analysts' average est. of $5/shr - LSEG ** Says quarterly profit slipped 1% due to higher expenses ** Company's quarterly revenue of $8.39 bln beats analysts' average expectation of $8.37 bln ** AMGN raises the lower end of its 2024 revenue outlook to a range of $32.8 bln to $33.8 bln from a previous low end forecast of
A

Amgen quarterly profit slips, obesity data on track for late 2024

UPDATE 2-Amgen quarterly profit slips, obesity data on track for late 2024 Adds analyst comment paragraph 4, company comment paragraph 10; updates share price By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses, including costs related to development of its experimental obesity drug MariTide, offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.
A

Amgen second quarter profit dips, sales rise 20%

Amgen second quarter profit dips, sales rise 20% By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. Amgen reported adjusted earnings of $4.97 per share, which was just short of the average analyst estimate of $5.00, according to LSEG data.
A

U.S. STOCKS IDEXX, Amgen, Airbnb

BUZZ-U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
I
U
U
F
M
R
U
V
M

PREVIEW: Amgen shares climb with results on tap

BUZZ-PREVIEW: Amgen shares climb with results on tap ** Amgen AMGN.O shares up 1.8% at $331.09 ahead of Q2 results due after the closing bell amid broad market recovery from three-day selloff ** The biotech company is expected to post EPS of $5.01 on revenue of $8.33 bln, per LSEG data, vs yr-ago results of $5.00 in EPS and $6.99 bln in revenue **
A
U

Rollercoaster markets, Nikkei rebounds 10%

MORNING BID AMERICAS-Rollercoaster markets, Nikkei rebounds 10% A look at the day ahead in U.S. and global markets from Mike Dolan The speed and scale of Tuesday's 10% Tokyo bounce after its worst day in 37 years suggests the wild global market swings of the past week are more rooted in speculative churn than economic fright. While that's only partly reassuring - as persistent market turbulence can itself sap economic activity - there's good reason to believe a slowing U.S.
A
C
N
U
W
J
U
U
U
F
F
D
I
J
M
S
B



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.